| Revenues | | 10,678.00 | 9,301.00 | 9,679.00 | 9,136.00 |
| | 1,830.00 | - | - | - |
| Selling, General, and Administrative | | 1,830.00 | - | - | - |
| Research and Development | | 922.00 | - | - | - |
| Costs And Expenses | | 9,931.00 | 8,831.00 | 9,687.00 | 8,889.00 |
| Operating Income/Loss | | 747.00 | 470.00 | -8.00 | 247.00 |
| Income/Loss From Equity Method Investments | | 25.00 | 17.00 | 5.00 | 32.00 |
| Income/Loss From Continuing Operations Before Tax | | 699.00 | 433.00 | -261.00 | 288.00 |
| Income Tax Expense/Benefit, Deferred | | -115.00 | -151.00 | -491.00 | -31.00 |
| Income Tax Expense/Benefit | | 75.00 | -19.00 | -436.00 | -17.00 |
| | 624.00 | 452.00 | 175.00 | 305.00 |
| Attributable To Parent | | 624.00 | 452.00 | 175.00 | 305.00 |
| Available To Common Stockholders, Basic | | 595.00 | 423.00 | 146.00 | 276.00 |
| Basic Average Shares | | 1,335.00 | 1,334.00 | 3.00 | 1,325.00 |
| Diluted Average Shares | | 1,432.00 | 1,356.00 | 3.00 | 1,421.00 |
| Basic Earnings Per Share | | 0.45 | 0.32 | 0.12 | 0.21 |
| Diluted Earnings Per Share | | 0.44 | 0.31 | 0.12 | 0.21 |
| Common Stock Dividends | 0.14 | 0.14 | 0.14 | 0.13 | 0.13 |